PLF

Latest TrueCut Motion Titles to be Demonstrated at CinemaCon 2024

Retrieved on: 
Thursday, April 4, 2024
Movie, 3D, Motion, HDR, PLF, Argylle, HFR, Film industry

LAS VEGAS, April 4, 2024 /PRNewswire/ -- Pixelworks today announced that demonstrations of the Company's breakthrough TrueCut Motion™ format used in "Argylle", "Kung-Fu Panda 4" and "Godzilla X Kong: The New Empire" will be shown on a CINITY Cinema System that uses Christie projection in the Christie solutions area, Milano Ballroom I, at CinemaCon 2024.  Utilizing its revolutionary and patented motion grading process, the dazzling world of each film looks even more stunning in the premium TrueCut Motion format.

Key Points: 
  • LAS VEGAS, April 4, 2024 /PRNewswire/ -- Pixelworks today announced that demonstrations of the Company's breakthrough TrueCut Motion™ format used in "Argylle", "Kung-Fu Panda 4" and "Godzilla X Kong: The New Empire" will be shown on a CINITY Cinema System that uses Christie projection in the Christie solutions area, Milano Ballroom I, at CinemaCon 2024.
  • Utilizing its revolutionary and patented motion grading process, the dazzling world of each film looks even more stunning in the premium TrueCut Motion format.
  • It improves the overall quality with clearer images, brighter colors, immersive sound and smoother motion for an unforgettable cinematic experience.
  • For more information on these demonstrations in the Christie solutions area in Milano Ballroom I at CinemaCon 2024, please contact:
    Pixelworks and TrueCut Motion are trademarks of Pixelworks, Inc.

Dolby Expanding the Best Way to Experience Movies by Making Dolby Vision and Dolby Atmos Available to All Premium Theater Exhibitors

Retrieved on: 
Tuesday, April 2, 2024
Atmos, Dolby Cinema, Sound, DLB, Caesars Palace, Colosseum, SAN, History, Dolby Atmos, Dolby Vision, Engineering, Life, Science, PLF, Cassette tape

Dolby Cinema is the ultimate moviegoing experience, providing a Dolby-designed environment that showcases the best implementation of Dolby Vision and Dolby Atmos.

Key Points: 
  • Dolby Cinema is the ultimate moviegoing experience, providing a Dolby-designed environment that showcases the best implementation of Dolby Vision and Dolby Atmos.
  • Dolby Cinema generates the highest average per screen box office amongst all premium large format (PLF) offerings.
  • This new solution gives exhibitors access to the visceral and awe-inspiring experience of Dolby Vision picture quality together with Dolby Atmos immersive sound – the same technologies that power Dolby Cinema, allowing audiences to see, hear and feel the film exactly as the filmmaker intended.
  • *
    Since the opening of the first Dolby Cinema in 2014, Dolby Cinema has grown rapidly, encompassing 28 exhibitor partners and 14 countries.

Do No Harm Challenges Montana's Race and Gender Balancing on Public Boards 

Retrieved on: 
Tuesday, March 12, 2024
Equal Protection Clause, DNH, Pacific Legal Foundation, Do No Harm, Fourteenth Amendment, District court, Patient, News, Publication, Amendment, PLF, Nursing, Physician

RICHMOND, Va., March 12, 2024 /PRNewswire/ -- Today, the medical watchdog group Do No Harm filed a federal lawsuit against Governor Gianforte in his official capacity as Governor of the state of Montana, to stop Montana's unlawful use of race and gender mandates in appointments to the Montana Board of Medical Examiners. 

Key Points: 
  • Do No Harm seeks a permanent prohibitory injunction preventing Governor Gianforte from enforcing or attempting to enforce the racial and gender mandate.
  • "Requiring the governor to consider the race and gender of candidates for the medical board is demeaning, patronizing, un-American, and unconstitutional," said PLF attorney Caleb Trotter.
  • A permanent injunction forbidding the Governor and the Governor's agents from enforcing, or attempting to enforce, the gender and racial mandates.
  • The case is Do No Harm v. Greg Gianforte in the U.S. District Court for the District of Montana.

ReNew Signs Contract to Sell 300 MW Solar Project at a Valuation of $199 Million

Retrieved on: 
Monday, January 8, 2024
Other Energy, Environment, Utilities, Alternative Energy, Green Technology, Energy, Sale, PPA, INR, PLF, Renewable energy

ReNew (“ReNew”) (NASDAQ: RNW, RNWWW), India’s leading decarbonization solutions company, announced on Monday that it has signed a Share Purchase Agreement with India Grid Trust to sell a 300 MW solar project in Rajasthan – ReNew Solar Urja Private Limited – for a total enterprise value of $199 million.

Key Points: 
  • ReNew (“ReNew”) (NASDAQ: RNW, RNWWW), India’s leading decarbonization solutions company, announced on Monday that it has signed a Share Purchase Agreement with India Grid Trust to sell a 300 MW solar project in Rajasthan – ReNew Solar Urja Private Limited – for a total enterprise value of $199 million.
  • Approximately $8 million is expected to be additionally received as an earn-out on account of change-in-law proceeds, after the first payment is realized by RSUPL.
  • After the transfer of the outstanding debt to the buyer, the transaction will result in a cash inflow of approximately $82 million, including change-in-law proceeds for ReNew.
  • In 2022-23, the solar project delivered a net PLF of 27.42%.

Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA

Retrieved on: 
Thursday, January 4, 2024
Clinical trial, Patient, Food, Smoker, Principal, Extremities, FDA, Kuros, Surgeon, PLF, Fair, Magneto, Spine, Schlieren, T10, Pelvis

In this trial, MagnetOs was evaluated as a standalone alternative to autograft in an instrumented posterolateral fusion (PLF) model in 91 patients and a total of 130 segments.

Key Points: 
  • In this trial, MagnetOs was evaluated as a standalone alternative to autograft in an instrumented posterolateral fusion (PLF) model in 91 patients and a total of 130 segments.
  • Notably, 20% of the patients in this study were smokers – an extremely challenging patient population when it comes to achieving fusion.
  • These fusion rates appear to exceed those of other bone graft substitutes we have previously studied in this indication.
  • MagnetOs Easypack Putty has become the second product in the MagnetOs portfolio to be cleared for use in the interbody space by FDA.

DO NO HARM CHALLENGES TENNESSEE'S RACIAL QUOTAS FOR STATE BOARDS AND COMMISSIONS

Retrieved on: 
Wednesday, November 8, 2023
Government, Physician, PLF, Publication, News, DNH, National Board of Podiatric Medical Examiners, Pacific Legal Foundation, Podiatry, District court, Do No Harm, Tennessee Board of Regents, Volunteering, Safety, Nursing, Patient, Patient safety

The Tennessee Board of Podiatric Medical Examiners requires one board member to be a racial minority, which has nothing to do with podiatry.

Key Points: 
  • The Tennessee Board of Podiatric Medical Examiners requires one board member to be a racial minority, which has nothing to do with podiatry.
  • "State medical boards are given important responsibilities to oversee the quality of care in their state and the safety of patients.
  • "Tennessee law forces governor after governor to engage in racial discrimination when making appointments to state boards and commissions," said Laura D'Agostino, an attorney with Pacific Legal Foundation who are bringing the suit pro-bono.
  • Tennessee is far from the only state that uses immutable characteristics to limit opportunities for individuals to serve their state and local communities.

Galaxy Theatres elevates movie experience with Christie RGB pure laser cinema projectors in select auditoriums

Retrieved on: 
Friday, October 13, 2023
Partnership, Multimedia, RGB, Gig Harbor, Washington, DFX, Christie's, Galaxy, Marketing, PLF, Cineplex Entertainment, DCI, REC, Entertainment, Television, Film industry, Cinema

SHERMAN OAKS, Calif., Oct. 13, 2023 /PRNewswire-PRWeb/ -- Galaxy Theatres is elevating the cinematic experience for its guests by introducing Christie® RGB pure laser cinema projectors in select recently updated Digital Fusion Experience (DFX) auditoriums.

Key Points: 
  • Galaxy Theatres is elevating the cinematic experience for its guests by introducing Christie® RGB pure laser cinema projectors in select recently updated Digital Fusion Experience (DFX) auditoriums.
  • SHERMAN OAKS, Calif., Oct. 13, 2023 /PRNewswire-PRWeb/ -- Galaxy Theatres is elevating the cinematic experience for its guests by introducing Christie® RGB pure laser cinema projectors in select recently updated Digital Fusion Experience (DFX) auditoriums.
  • To complete this luxury cinematic experience, Christie CP4430-RGB pure laser cinema projectors, featuring Real|Laser™ illumination, have recently been installed by Southern California Cinetech Services in the DFX auditoriums located at Galaxy Theatres Cannery in Nevada and Gig Harbor and Monroe in Washington.
  • "We're thrilled that Galaxy Theatres has continued to place their trust in Christie to help them deliver a premium moviegoing experience for their guests through a self-branded large format DFX experience."

Christie to elevate cinema experience for Chinese audiences at BIRTV

Retrieved on: 
Friday, August 18, 2023
Xenon, ECC, Christie, CineEurope, UI, Film distribution, Exhibition, China International Exhibition Center, Electronics, TB, Multimedia, Carbon, SSD, Christie's, World's fair, PLF, UX, Architecture, Film industry, Television

BEIJING, Aug. 18, 2023 /PRNewswire-PRWeb/ -- Christie® will elevate the cinema experience for Chinese audiences with industry-leading cinema solutions ideal for both mainstream and Premium Large Format (PLF) auditoriums at the Beijing International Radio, TV and Film Exhibition (BIRTV), to be held at the China International Exhibition Center from August 23-26.

Key Points: 
  • BEIJING, Aug. 18, 2023 /PRNewswire-PRWeb/ -- Christie® will elevate the cinema experience for Chinese audiences with industry-leading cinema solutions ideal for both mainstream and Premium Large Format (PLF) auditoriums at the Beijing International Radio, TV and Film Exhibition (BIRTV), to be held at the China International Exhibition Center from August 23-26.
  • The event is also an excellent platform to showcase Christie's latest cinema technologies geared towards enriching the moviegoer experience, optimizing operational efficiency, and reducing costs.
  • "BIRTV has emerged as the go-to event for the finest minds to connect within this dynamic market in the post-pandemic world," said James Li, executive director, China Cinema, Christie.
  • Visitors can also check out two remarkable cinema projectors on static display – the Christie CP4455-RGB pure laser projector and the Christie CP2415-Xe projector.

Christie to serve as official technology partner of Big Cine Expo 2023

Retrieved on: 
Friday, August 4, 2023
Christie, Partnership, Chennai Trade Centre, Series 4, Electronics, Carbon, Christie's, Survival, PLF, Growth, Survival of the fittest, Film industry, Cinema, Xenon

CHENNAI, India, Aug. 4, 2023 /PRNewswire-PRWeb/ -- Christie®, the leader in inspiring exceptional experiences, is proud to announce its ongoing partnership with Big Cine Expo 2023 as the event's official technology partner for the sixth consecutive year.

Key Points: 
  • CHENNAI, India, Aug. 4, 2023 /PRNewswire-PRWeb/ -- Christie®, the leader in inspiring exceptional experiences, is proud to announce its ongoing partnership with Big Cine Expo 2023 as the event's official technology partner for the sixth consecutive year.
  • "We are delighted that Christie is once again serving as the official technology partner for our annual convention, where we proudly present the finest content from Indian cinema," said Raghavendra T, director of Big Cine Expo.
  • "Christie's long-standing association with cutting-edge cinema projection technologies has played a pivotal role in the growth of Big Cine Expo.
  • Christie's participation at Big Cine Expo 2023 includes two speaking engagements relevant to today's state of the industry.

Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial

Retrieved on: 
Thursday, July 13, 2023
Spinal fusion, CT, Surgeon, Brigham and Women's Hospital, Degenerative disc disease, UCSD, PTH, Kuros, Investigational New Drug, Patient, DDD, PLF, Hospital, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, IND, Food, Safety, Pharmaceutical industry, Medical imaging

Fibrin-PTH is a novel parathyroid hormone-based healing matrix allowing targeted, controlled bone generation.

Key Points: 
  • Fibrin-PTH is a novel parathyroid hormone-based healing matrix allowing targeted, controlled bone generation.
  • Fibrin-PTH targets a substantial clinical need and, upon approval, will address the large musculoskeletal growth factor market projected to reach $2.2B by 2030.
  • The primary endpoint of the trial is radiographic interbody fusion using CT scans at 12 months, as determined by an independent radiology expert panel.
  • Upon successful completion of the Phase 2 study, the Phase 3 program will be initiated.